KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Debt to Equity (2020 - 2025)

Historic Debt to Equity for Fulgent Genetics (FLGT) over the last 6 years, with Q3 2025 value amounting to $0.03.

  • Fulgent Genetics' Debt to Equity rose 444.01% to $0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.03, marking a year-over-year increase of 444.01%. This contributed to the annual value of $0.03 for FY2024, which is 1759.4% up from last year.
  • Latest data reveals that Fulgent Genetics reported Debt to Equity of $0.03 as of Q3 2025, which was up 444.01% from $0.03 recorded in Q2 2025.
  • Fulgent Genetics' 5-year Debt to Equity high stood at $0.06 for Q2 2021, and its period low was $0.01 during Q2 2023.
  • In the last 5 years, Fulgent Genetics' Debt to Equity had a median value of $0.02 in 2023 and averaged $0.02.
  • Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 6028.92% in 2022, then soared by 12326.61% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Debt to Equity stood at $0.02 in 2021, then decreased by 14.84% to $0.01 in 2022, then skyrocketed by 56.15% to $0.02 in 2023, then rose by 17.59% to $0.03 in 2024, then grew by 1.98% to $0.03 in 2025.
  • Its last three reported values are $0.03 in Q3 2025, $0.03 for Q2 2025, and $0.03 during Q1 2025.